Aethlon Medical Inc. Reports Warrant Exercises; 1.60M Shares Outstanding

What Happened

• Aethlon Medical Inc. filed a Form 8-K (Item 8.01) disclosing that, following recent exercises of pre-funded warrants, all previously outstanding pre-funded warrants have been exercised.
• The company reported 1,604,095 shares of common stock outstanding as of the close of business on August 28, 2026.

Key Details

• Filing type: Form 8-K, Item 8.01 (Other Events).
• Shares outstanding: 1,604,095 as of August 28, 2026.
• Status of warrants: All previously outstanding pre-funded warrants have been exercised (no pre-funded warrants remain outstanding).
• The 8-K was filed on August 31, 2026 (disclosing the August 28, 2026 share count).

Why It Matters

• Updated share count: The 1,604,095 figure is the company's current basic shares outstanding and should be used when calculating ownership percentages, per-share metrics, or basic market-cap estimates.
• Capital structure change: Exercising pre-funded warrants removes that warrant class from the capital structure and can affect dilution and voting interests; the filing does not disclose exercise prices or proceeds.
• Investors tracking dilution, ownership, or preparing valuation calculations should note this updated share total disclosed in the 8-K.